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Purpose: To report the outcomes of surgical and non-surgical treatment in sixth 
nerve paresis and palsy.
Methods: This retrospective study was performed on hospital records of 33 consecutive 
patients (37 eyes) with sixth nerve dysfunction who were referred to Labbafinejad 
Medical Center from September 1996 to September 2006, and underwent surgical 
procedures or botulinum toxin injection. Patients were divided into three groups: 
group A had muscle surgery without transposition, group B underwent transposition 
procedures and group C received Botulinum toxin injection.
Results: Overall, 33 patients including 19 male and 14 female subjects with mean 
age of 20.4±17.2 years (range, 6 months to 66 years) were studied. Eye deviation 
improved from 50.3±16.8 to 6.0±9.8 prism diopters (PD) after the first operation 
and to 2.5±5.0 PD after the second operation in group A, from 56.9±24.3 to 5.5±16.0 
PD after the first procedure and to almost zero following the second in group B, 
and from 44.3±10.5 to 15.0±20.0 PD 6 months following botulinum toxin injection in 
group C. Head posture and limitation of motility also improved significantly in all 
three groups. The overall rate of reoperations was 21%.
Conclusions: Various procedures are effective for treatment of sixth nerve dysfunction; 
all improve ocular deviation, head turn and abduction deficit. The rate of reoperation 
is not high when treatment is appropriately selected according to clinical condition.
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INTRODuCTION
Paralytic strabismus poses a significant diagnostic 
and therapeutic challenge. Congenital and 
acquired sixth nerve palsy has been shown to be 
the most common type of cerebral nerve palsy 
in some studies,1 comprising up to 45 percent 
of referrals for cerebral nerve palsy.2 Due to its 
long intracranial path, its angle at the petrous 
tip of the temporal bone and non-flexibility 
of the path between the brainstem and the 
meningeal entrance site; the abducens nerve 
is susceptible to damage with various types 
of intracranial pathologies such as meningeal 
inflammation or edema and any displacement 
of the brain stem. The sixth cranial nerve, 
similar to other cranial nerves, is also sensitive 
to toxic substances, demyelinative processes 
and viral diseases.3
Congenital sixth nerve paresis is uncommon 
and difficult to distinguish from congenital 
esotropia, Duane’s syndrome and Mobius Treatment of Sixth Nerve Palsy; Bagheri et al
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syndrome.4 The acquired variant improves 
spontaneously over 3 to 6 months; based on 
current information, 78% of patients recover 
in one year and 40% of the remaining cases 
have a severe underlying condition such as 
intracranial aneurysms or vascular disorders 
(brainstem stroke), carotid-cavernous fistula 
or cerebral tumors.5-6
In patients with slow improvement, 
contracture of the medial rectus muscle may 
result in concomitant esotropia with positive 
forced duction test (FDT). After identifying the 
underlying cause, several interventions such as 
patching, compensatory prisms or Botulinium 
toxin injections are used to prevent diplopia 
and abnormal head posture in the first 6 months 
following sixth nerve palsy. When esotropia is 
not improving and becomes stable for at least 
6 months, surgical intervention is warranted. 
A variety of procedures may be performed 
such as recession and resection (R&R), bilateral 
medial rectus recession (BMR), different muscle 
transposition procedures (Hummelschiem and 
Jensen) with or without medial rectus (MR) 
recession, and bilateral lateral rectus (LR) 
resection along with medial rectus myotomy.
In this study, we present the clinical 
features of a consecutive series of patients 
with sixth nerve palsy over a 10-year period 
at Labbafinejad Medical Center (LMC) and the 
outcomes of medical and surgical treatment 
for this condition.
METHODS
This retrospective study was performed on 
hospital records of consecutive patients with 
sixth nerve palsy who were referred to LMC, 
Tehran, Iran from September 1996 to September 
2006. Relevant data included age, gender, reason 
for referral, laterality of the palsy, angle of 
deviation, head posture, limitation of motility 
(from -1 to -4; indicating abduction deficit of 
25% to 100%), positive FDT, type of treatment 
(surgical versus non-surgical), and etiology of 
sixth nerve dysfunction (congenital, traumatic, 
ischemic, infectious, tumoral or inflammatory). 
The type and number of operations were also 
determined which included R&R, BMR, MR 
myotomy, LR resection, full tendon transposition 
with or without MR recess and Jensen’s 
procedure. Patients were followed one day, 
one and 6 weeks, and 3 months after surgery. 
Further follow-up visits were arranged based 
on the condition of the individual patient.
Visual acuity was measured using Snellen 
optotypes where possible; fixation patterns 
were used for preverbal children to determine 
centration, steadiness and maintenance (CSM) 
of fixation.
Patients were divided into 3 different 
groups;  group  A  underwent  surgical 
intervention without transposition, group B 
underwent muscle transposition, and group 
C received one dose (10-20 unit) of Botulinum 
toxin (Dysport, Ipsen, Slough, UK) injected 
into the MR muscle. Data were compared pre- 
and postoperatively using paired t-test with 
significance level set at P<0.05.
RESuLTS
This study included 33 patients consisting of 
19 (57.6%) male and 14 (42.4%) female subjects 
with mean age of 20.4±17.2 years (range, 6 
months to 66 years) (Fig. 1). Mean follow-up 
was 17.1±25.3 months and for groups A, B, and 
C, 19.3±31.9, 18.1±21.6, and 11.2±10.2 months 
respectively. The right eye was involved in 
10 (30.3%) subjects, the left eye in 19 (57.6%) 
patients and both eyes in the other 4 (12.1%) 
individuals. Chief complaints included squint 
Figure 1. Patients’ age distribution.Treatment of Sixth Nerve Palsy; Bagheri et al
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in 30 (91.0%) cases, diplopia in 7 (21.2%) cases 
and abnormal head posture in one (3.0%) 
patient (Fig. 2). The sixth nerve dysfunction 
was traumatic in 18 (54.4%) cases, congenital 
in 6 (18.2%) patients, due to viral infections 
in 6 (18.2%) individuals, secondary to tumors 
in 2 (6.1%) subjects, and ischemic in 1 (3%) 
patient (Fig. 3).
Regarding treatment, 17 cases (51.5%) 
were operated without muscle transposition 
(group A), 8 subjects (24.2%) underwent muscle 
transposition (group B), and 8 individuals (24.2%) 
received Botulinum toxin injections (group C). 
Seven (21%) patients required a second procedure 
including 4 cases in the transposition group, 2 in 
the R&R group and one in the Botulinium group. 
Table 1 shows mean eye deviation before and after 
the first and second operations. Preoperatively, 
mean deviation was 50.3±17.7 (range, 18-100) 
PD overall, which was reduced to 9.0±13.8 PD 
(range, 50 PD esotropia to 16 PD exotropia) after 
the first operation, and 1.7±3.1 (range, 0-10) PD 
after the second procedure (Table 1, P<0.001). In 
the transposition group, 4 patients received full 
tendon transposition with MR recess, 3 patients 
underwent full tendon transposition without 
MR recess, and one patient underwent Jensen’s 
procedure together with MR recess.
Mean preoperative amount of head posture 
was 15.0±8.9, 11.3±6.3 and 15.0±7.1 degrees in 
groups A, B and C respectively which reached 
zero postoperatively (P= 0.03, 0.07 and 0.20 
respectively). Preoperatively, mean limitation 
of motility was -2.7±1.2 in the non-transposition 
group, -4.0±0.9 in the transposition group and 
-3.6±0.7 in the Botulinium group, which reached 
-9.0±1.0 (P=0.002), -3.0±0.9 (P=0.02) and -1.2±1.4 
(P=0.04), respectively (Fig. 4).
Comparing the outcomes of treatment 
among the three groups, improvements in eye 
deviation (P=0.3) and head posture (P=0.9) were 
not significantly different. However, ocular 
deviation was significantly less corrected with 
muscle transposition (P=0.001). The greater the 
primary deviation and limitation of motility, 
the larger the improvement (Figures 5 and 6, 
Spearman correlation). Furthermore, the higher 
the primary deviation, the better the response 
to primary strabismus surgery (Fig. 7, Spearman 
correlation).
Groups Preoperation After first operation After second operation
A (Non-transposition) 56.9±24.3 5.5±16.0 0
B (Transposition) 50.3±16.8 6.0±9.8 2.5±5.0
C (Botulinium*) 44.3±10.5 15.0±20.0 0
Total  50.3±17.7 9.0±13.8 1.7±3.1
Table 1. Preoperative and postoperative mean ± SD ocular deviation (prism diopters) in different groups
SD, standard deviation; *only one patient in this group required a second injection.
Figure 2. Chief complaints of the patients.
Figure 3. Etiology of sixth nerve palsy.Treatment of Sixth Nerve Palsy; Bagheri et al
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DISCuSSION
Sixth nerve palsy has been reported to be the 
most common type of extraocular nerve paralysis 
based on some studies2,7, but ranking second 
following fourth nerve palsy according to other 
reports.8-10 This condition has been reported to 
be more prevalent in male subjects7,10 which 
may be due to the higher rate of trauma in men, 
especially accidents and work related injuries.
Among acquired cases of sixth nerve palsy 
in our series, trauma was the most common 
cause followed by viral infections, tumors 
and cerebral ischemia. Although more than 
80% of patients had acquired dysfunction, the 
most prevalent chief complaint was squint 
rather than diplopia. This may be explained 
Figure 5. Correlation between baseline eye deviation and 
postoperative improvement.
Group A (R2: 0.945, P<0.001)
Group B (R2: 0.836, P: 0.001)
Group C (R2: 0.177, P: 0.299)
Figure 7.  Correlation  between  primary  and  residual 
deviation after first surgery.
Figure 6.  Correlation  between  baseline  limitation  and 
postoperative improvement.
Group A (R2: 0.395, P: 0.012)
Group B (R2: 0.167, P: 0.315)
Group C (R2: 0.193, P: 0.384)
Figure 4.  Changes  in  limitation  of  eye  movements  in 
different study groups.Treatment of Sixth Nerve Palsy; Bagheri et al
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by the young patient population (most subjects 
were in their first decade of life) with higher 
potential for suppression. We have shown in two 
previous reports from our center that congenital 
causes of palsies comprise less than 20% of all 
cases.7,10 Ariochane11 studied 64 patients with 
sixth nerve dysfunction less than 7 years of 
age and reported hydrocephalus as the most 
common cause followed by trauma, congenital 
conditions and viral infections. In a study on 
132 patients younger than 18 years with sixth 
nerve palsy, Afifi et al12 reported the causes in 
descending order: trauma, tumors, congenital 
disorders, viral infections and hydrocephalus. 
In a study by Robertson et al13 on 103 patients 
under 15 years of age, the leading cause was 
tumors followed by trauma, inflammation and 
idiopathic. Mittleman et al,14 in a study on 
64 children under 7 years, observed the most 
common causes to be tumors, hydrocephalus 
and trauma.
The highest success rate was gained after 
primary intervention such that only 21% of our 
patients required a second intervention, most 
in the transposition group (4 cases). After the 
first operation, the best result was observed 
in the group with no transposition and the 
worst response was found in the Botulinum 
group. Therefore, it may be concluded that 
proper selection of treatment based on the 
severity of paresis, its onset and the amount 
of motility limitation can increase the chance 
for an optimal response. The most significant 
level of limitation of motility was observed in 
the transposition group. As expected, the most 
significant level of improvement in limitation 
was gained with non-transposition procedures, 
while the Botulinium group had an intermediate 
situation.
As shown in figure 2, the more severe the 
primary deviation, the greater the improvement 
after surgery. In other words, strabismus 
surgery has a self-adjustable nature, i.e. the 
same procedure results in greater response 
with more severe strabismus. However, as the 
primary deviation increases, residual deviation 
also increases. When primary limitation of 
motility increases, improvement also increases 
after surgery; a steeper slope was observed 
in the non-transposition group. Despite 
improvement in primary position deviation, 
eyes in the transposition group which were 
completely paralyzed had the least amount of 
improvement in limitation of motility.
The significant improvement in the 
Botulinium group reflects the possibility of 
utilizing minimally invasive methods such 
as Botulinum toxin. In a study on 33 patients 
with a clinical diagnosis of acute traumatic 
sixth nerve paresis, Holmes et al15 showed 
that 86% of unilateral and 38% of bilateral 
cases improved spontaneously after 3 months 
and recommended that Botulinum toxin can 
prevent MR fibrosis during the period of self-
improvement.
In conclusion, the effect of strabismus 
surgery in sixth nerve palsy appears to be 
self-adjustable and if the procedure is selected 
appropriately, the success rate is high with only 
one patient out of five requiring a reoperation.
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